Cefepime/Zidebactam

N/A

Report date: 2025/02/11 16:54:55
QIDP

Base Information

Drug NameCefepime/Zidebactam
Drug Alias NameZidebactam+CefepimeZidebactam/CefepimeCefepime+ZidebactamZidebactam/cefepime intravenousZaynich +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsPseudohypoaldosteronismRenal InsufficiencyPyelonephritis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesSlovakia +[9] 
CombinationsYes Zidebactam
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesWockhardt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Bio AgWockhardt LtdAcs Dobfar SPA +[4] 
Inactive CompaniesN/A
Active IndicationsPseudohypoaldosteronismPyelonephritisUrinary Tract Infections
Inactive IndicationsRenal InsufficiencyGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A